New review guidelines

files full of paper

PSA has updated its QUM and medicines reviews guidelines, in a “timely” move just after these were expanded

The PSA announced in a statement that it has updated its practice guidelines for pharmacists on conducting medication management reviews, as well as providing Quality Use of Medicines services, to residential aged care facilities.

The updated guidelines incorporate current best practice when providing these services, says PSA.

The Guidelines for comprehensive medication management reviews provide pharmacists with best practice guidance when providing medication management review services, such as Home Medicines Reviews (HMRs) and Residential Medication Management Reviews (RMMRs), it says.

PSA National President Associate Professor Chris Freeman said the updates to these guidelines are timely given the recent Federal Government announcements to make medication review programs available via telehealth and allow two additional HMR and RMMR follow-ups with patients following the initial review.

”The revised guidelines are designed to support pharmacists in providing quality medication management services and improve the quality use of medicines in the community,” he said.

“Pharmacists have an important role to play in reducing medication-related harm and ensuring medicines are used safely and appropriately.

”These guidelines will also provide guidance and support for pharmacists in implementing program changes in practice, such as the utilisation of follow-ups after the initial HMR or RMMR.”

This week the Federal Government and PSA announced that accredited pharmacists will be allowed two additional follow-ups for HMRs and RMMRs with patients within nine months of the initial review.

Previously they were allowed one review per patient every 24 months.

This followed last week’s announcement that eligible patients will be able to access medication reviews from a pharmacist via video or teleconference from Tuesday 21 April, a measure undertaken as a result of the COVID-19 pandemic.

The PSA’s new guidelines include guidance on considerations when recommending and undertaking follow-ups after the initial review, as well as highlighting the importance of collaboration and communication with the healthcare team and the role of pharmacists as part of this team when providing medication management review services.

The Guidelines for Quality Use of Medicines services provides best practice guidance for pharmacists providing Quality Use of Medicines services in residential aged care facilities, says PSA.

Information is provided on how to plan and undertake QUM activities that form part of a QUM Plan for the facility and will contribute to continuous quality improvement.

There are also examples of QUM activities that pharmacists may undertake and suggestions for the frequencies at which these activities should be undertaken are provided.

These Guidelines have been developed with funding provided by the Australian Government Department of Health and can be found here.

Previous Supporting the farming community
Next Stuck pharmacy burglar called cops for help

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.

No Comment

Leave a reply